Somnomed Limited Stock Price Patterns
| SOMNF Stock | USD 0.51 0.00 0.00% |
Momentum 100
Buy Peaked
Oversold | Overbought |
Using SomnoMed hype-based prediction, you can estimate the value of SomnoMed Limited from the perspective of SomnoMed response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in SomnoMed to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying SomnoMed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
SomnoMed after-hype prediction price | USD 0.51 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
SomnoMed |
SomnoMed After-Hype Price Density Analysis
As far as predicting the price of SomnoMed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in SomnoMed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of SomnoMed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
SomnoMed Estimiated After-Hype Price Volatility
In the context of predicting SomnoMed's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on SomnoMed's historical news coverage. SomnoMed's after-hype downside and upside margins for the prediction period are 0.03 and 1.90, respectively. We have considered SomnoMed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
SomnoMed is dangerous at this time. Analysis and calculation of next after-hype price of SomnoMed Limited is based on 3 months time horizon.
SomnoMed Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as SomnoMed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SomnoMed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SomnoMed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.18 | 1.39 | 0.00 | 0.01 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.51 | 0.51 | 0.00 |
|
SomnoMed Hype Timeline
SomnoMed Limited is at this time traded for 0.51. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. SomnoMed is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.18%. %. The volatility of related hype on SomnoMed is about 2074.63%, with the expected price after the next announcement by competition of 0.52. About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of SomnoMed was at this time reported as 0.34. The company recorded a loss per share of 0.04. SomnoMed Limited had not issued any dividends in recent years. The entity had 106:91 split on the 26th of March 2020. Assuming the 90 days horizon the next estimated press release will be within a week. Check out SomnoMed Basic Forecasting Models to cross-verify your projections.SomnoMed Related Hype Analysis
Having access to credible news sources related to SomnoMed's direct competition is more important than ever and may enhance your ability to predict SomnoMed's future price movements. Getting to know how SomnoMed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how SomnoMed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SNZZF | Senzime AB | 0.00 | 0 per month | 0.00 | (0.01) | 0.00 | 0.00 | 22.41 | |
| PFGTF | Pacific Edge Limited | 0.00 | 0 per month | 0.00 | (0.03) | 0.00 | 0.00 | 99.18 | |
| LDXHF | Lumos Diagnostics Holdings | 0.00 | 0 per month | 9.96 | 0.08 | 28.57 | (22.22) | 68.57 | |
| TOKIF | Optima Medical Innovations | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AURX | Nuo Therapeutics | 0.67 | 5 per month | 0.00 | (0.11) | 7.50 | (7.45) | 23.25 | |
| CORBF | Global Cord Blood | 0.00 | 0 per month | 6.52 | 0.12 | 26.67 | (15.79) | 131.82 | |
| VTIAF | VITA 34 AG | 0.00 | 0 per month | 0.00 | (0.21) | 0.00 | 0.00 | 8.86 | |
| ORXOF | Orexo AB | 0.00 | 0 per month | 0.00 | (0.0003) | 0.00 | 0.00 | 5.90 | |
| GRUSF | Grown Rogue International | 0.00 | 0 per month | 4.70 | 0.04 | 8.70 | (6.98) | 48.44 | |
| SHIEF | Shield Therapeutics plc | 0.00 | 0 per month | 0.00 | 0.10 | 7.14 | 0.00 | 61.79 |
SomnoMed Additional Predictive Modules
Most predictive techniques to examine SomnoMed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SomnoMed using various technical indicators. When you analyze SomnoMed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About SomnoMed Predictive Indicators
The successful prediction of SomnoMed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as SomnoMed Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of SomnoMed based on analysis of SomnoMed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to SomnoMed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to SomnoMed's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for SomnoMed Pink Sheet analysis
When running SomnoMed's price analysis, check to measure SomnoMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SomnoMed is operating at the current time. Most of SomnoMed's value examination focuses on studying past and present price action to predict the probability of SomnoMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SomnoMed's price. Additionally, you may evaluate how the addition of SomnoMed to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |